Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Cash from Restructuring (2016 - 2023)

Dentsply Sirona (XRAY) has disclosed Cash from Restructuring for 14 consecutive years, with -$6.0 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Cash from Restructuring fell 20.0% year-over-year to -$6.0 million, compared with a TTM value of -$15.0 million through Mar 2024, down 137.5%, and an annual FY2023 reading of $33.0 million, up 430.0% over the prior year.
  • Cash from Restructuring was -$6.0 million for Q4 2023 at Dentsply Sirona, down from -$3.0 million in the prior quarter.
  • Across five years, Cash from Restructuring topped out at $71.2 million in Q4 2020 and bottomed at -$6.0 million in Q2 2023.
  • Average Cash from Restructuring over 4 years is $11.3 million, with a median of $850000.0 recorded in 2019.
  • Peak annual rise in Cash from Restructuring hit 2500.0% in 2023, while the deepest fall reached 500.0% in 2023.
  • Year by year, Cash from Restructuring stood at $65.8 million in 2019, then rose by 8.21% to $71.2 million in 2020, then tumbled by 107.02% to -$5.0 million in 2022, then decreased by 20.0% to -$6.0 million in 2023.
  • Business Quant data shows Cash from Restructuring for XRAY at -$6.0 million in Q4 2023, -$3.0 million in Q3 2023, and -$6.0 million in Q2 2023.